Fig. 2From: Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 yearsKaplan-Meier curve of time until the decrease in Karnofsky performance status score (KPS) to below 60. The median time until KPS score decreased to below 60 was 7.9 months. Abbreviations: KPS Karnofsky performance statusBack to article page